Annual Short Term Debt
$550.00 K
-$41.00 K-6.94%
March 31, 2024
Summary
- As of February 8, 2025, VTGN annual short term debt is $550.00 thousand, with the most recent change of -$41.00 thousand (-6.94%) on March 31, 2024.
- During the last 3 years, VTGN annual short term debt has risen by +$182.20 thousand (+49.54%).
- VTGN annual short term debt is now -96.05% below its all-time high of $13.93 million, reached on March 31, 2015.
Performance
VTGN Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$525.00 K
-$42.00 K-7.41%
September 30, 2024
Summary
- As of February 8, 2025, VTGN quarterly short term debt is $525.00 thousand, with the most recent change of -$42.00 thousand (-7.41%) on September 30, 2024.
- Over the past year, VTGN quarterly short term debt has stayed the same.
- VTGN quarterly short term debt is now -96.23% below its all-time high of $13.93 million, reached on March 31, 2015.
Performance
VTGN Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
VTGN Short Term Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -6.9% | 0.0% |
3 y3 years | +49.5% | 0.0% |
5 y5 years | +812.1% | 0.0% |
VTGN Short Term Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -6.9% | +49.5% | -64.6% | +23.7% |
5 y | 5-year | -6.9% | +812.1% | -64.6% | +42.7% |
alltime | all time | -96.0% | >+9999.0% | -96.2% | >+9999.0% |
VistaGen Therapeutics Short Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $525.00 K(-7.4%) |
Jun 2024 | - | $567.00 K(+3.1%) |
Mar 2024 | $550.00 K(-6.9%) | $550.00 K(+2.7%) |
Dec 2023 | - | $535.40 K(+3.2%) |
Sep 2023 | - | $518.90 K(-59.7%) |
Jun 2023 | - | $1.29 M(+117.8%) |
Mar 2023 | $591.00 K(+36.4%) | $591.00 K(-33.7%) |
Dec 2022 | - | $891.10 K(-24.9%) |
Sep 2022 | - | $1.19 M(-19.9%) |
Jun 2022 | - | $1.48 M(+242.0%) |
Mar 2022 | $433.30 K(+17.8%) | $433.30 K(+2.1%) |
Dec 2021 | - | $424.40 K(+5.5%) |
Sep 2021 | - | $402.30 K(+5.7%) |
Jun 2021 | - | $380.60 K(+3.5%) |
Mar 2021 | $367.80 K(-1.4%) | $367.80 K(-18.9%) |
Dec 2020 | - | $453.50 K(-34.7%) |
Sep 2020 | - | $694.60 K(-8.4%) |
Jun 2020 | - | $758.00 K(+103.1%) |
Mar 2020 | $373.20 K(+518.9%) | $373.20 K(-0.5%) |
Dec 2019 | - | $375.10 K(-17.0%) |
Sep 2019 | - | $452.00 K(-14.3%) |
Jun 2019 | - | $527.50 K(+774.8%) |
Mar 2019 | $60.30 K(+6.7%) | $60.30 K(+16.0%) |
Dec 2018 | - | $52.00 K(-56.1%) |
Sep 2018 | - | $118.40 K(-35.6%) |
Jun 2018 | - | $183.80 K(+225.3%) |
Mar 2018 | $56.50 K(-1.2%) | $56.50 K(+22.0%) |
Dec 2017 | - | $46.30 K(-57.0%) |
Sep 2017 | - | $107.70 K(-35.9%) |
Jun 2017 | - | $167.90 K(+193.5%) |
Mar 2017 | $57.20 K | $57.20 K(+58.4%) |
Dec 2016 | - | $36.10 K(-49.7%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2016 | - | $71.70 K(-32.9%) |
Jun 2016 | - | $106.80 K(+138.9%) |
Mar 2016 | $44.70 K(-99.7%) | $44.70 K(-40.3%) |
Dec 2015 | - | $74.90 K(-30.3%) |
Sep 2015 | - | $107.50 K(-69.0%) |
Jun 2015 | - | $346.70 K(-97.5%) |
Mar 2015 | $13.93 M(+553.2%) | $13.93 M(+94.7%) |
Dec 2014 | - | $7.16 M(+88.9%) |
Sep 2014 | - | $3.79 M(+8.7%) |
Jun 2014 | - | $3.49 M(+63.4%) |
Mar 2014 | $2.13 M(+197.1%) | $2.13 M(+133.6%) |
Dec 2013 | - | $912.90 K(+17.4%) |
Sep 2013 | - | $777.40 K(-3.2%) |
Jun 2013 | - | $803.40 K(+11.9%) |
Mar 2013 | $717.80 K(-5.7%) | $717.80 K(-23.8%) |
Dec 2012 | - | $941.40 K(+14.5%) |
Sep 2012 | - | $822.10 K(-15.9%) |
Jun 2012 | - | $977.80 K(+28.5%) |
Mar 2012 | $761.20 K(>+9900.0%) | $761.20 K(+30.6%) |
Dec 2011 | - | $582.90 K(-83.9%) |
Sep 2011 | - | $3.62 M(+576.1%) |
Jun 2011 | - | $535.90 K(>+9900.0%) |
Mar 2011 | - | $500.00(0.0%) |
Dec 2010 | $500.00(0.0%) | $500.00(0.0%) |
Sep 2010 | - | $500.00(0.0%) |
Jun 2010 | - | $500.00(0.0%) |
Mar 2010 | - | $500.00(0.0%) |
Dec 2009 | $500.00(0.0%) | $500.00(0.0%) |
Sep 2009 | - | $500.00(0.0%) |
Jun 2009 | - | $500.00(0.0%) |
Dec 2008 | $500.00 | $500.00(0.0%) |
Jun 2008 | - | $500.00(0.0%) |
Mar 2008 | - | $500.00 |
FAQ
- What is VistaGen Therapeutics annual short term debt?
- What is the all time high annual short term debt for VistaGen Therapeutics?
- What is VistaGen Therapeutics annual short term debt year-on-year change?
- What is VistaGen Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for VistaGen Therapeutics?
- What is VistaGen Therapeutics quarterly short term debt year-on-year change?
What is VistaGen Therapeutics annual short term debt?
The current annual short term debt of VTGN is $550.00 K
What is the all time high annual short term debt for VistaGen Therapeutics?
VistaGen Therapeutics all-time high annual short term debt is $13.93 M
What is VistaGen Therapeutics annual short term debt year-on-year change?
Over the past year, VTGN annual short term debt has changed by -$41.00 K (-6.94%)
What is VistaGen Therapeutics quarterly short term debt?
The current quarterly short term debt of VTGN is $525.00 K
What is the all time high quarterly short term debt for VistaGen Therapeutics?
VistaGen Therapeutics all-time high quarterly short term debt is $13.93 M
What is VistaGen Therapeutics quarterly short term debt year-on-year change?
Over the past year, VTGN quarterly short term debt has changed by $0.00 (0.00%)